French quality stocks: why the prices differ so much

2026-09-02 · By Lubin Danilo, founder of Lubin Investment

Analyze a stock on Lubin Investment

Twenty-one French stocks, from Cegedim to Hermès, pass 8 or 9 of my 10 quality criteria today. Their stock prices still range from very cheap to very expensive, a gap of more than twenty times between the two extremes. None of them triggers my buy signal. Quality says nothing about price, and here is why.

Twenty-one French stocks pass my quality filter

I score every stock on ten concrete financial criteria, regardless of its country or size: is it profitable, do sales and free cash flow keep growing over time, does it buy back its own shares instead of diluting them, is its debt manageable, is its return on capital strong. I never look at the price at this stage. Quality and price are two separate questions, and I always answer the first before the second.

Applying this filter to every stock listed in Paris, with at least 6 of 10 criteria validated, 21 names show up today. The smallest, Klea Holding, is worth barely $46 million on the market. The biggest, L'Oréal, is worth more than $200 billion. In between sit names most people cross paths with without knowing they are publicly traded, JCDecaux on the street or Edenred in meal vouchers, and others known only to specialists, like Antin Infrastructure Partners or Klea Holding. Here are the 21, ranked by what they cost today relative to the cash they actually generate each year.

A gap of more than twenty times between the cheapest and the priciest

The number that organizes this table is called P/FCF, for price-to-free-cash-flow. It is the stock price divided by free cash flow, the money that really stays in the company's coffers once every bill is paid, including investment spending. A P/FCF of 5 means you are paying today for five years of that cash to own the stock. The lower the number, the cheaper the stock is relative to the cash it actually produces. It follows the same logic laid out by Aswath Damodaran, an NYU valuation professor whose work informs part of my method.

Across these 21 stocks, rated almost identically by my filter, P/FCF ranges from 1.8 for Cegedim to 38.3 for Hermès. At comparable quality, one stock trades at more than twenty times the price of another, relative to its cash. This is not an isolated fluke: three other names, Lagardère, Catering International & Services, and AXA, also trade below 5 times free cash flow, while Safran, Schneider Electric, and Euronext trade above 20 times. Quality, as I measure it, predicts almost nothing about the price the market is willing to pay.

Why Cegedim, Lagardère, and AXA stay cheap

Cegedim is the cheapest of the 21. It is a French health-data company, founded in 1969, that collects and distributes medical information for healthcare professionals, insurers, and businesses, across three lines: health insurance and HR, healthcare professionals, and cloud services. It employs a little over 6,500 people in nearly 80 countries and generated 654.5 million euros in revenue in 2024, up 6.25% year over year. Its market cap, around 146 million euros, makes it a micro-cap, too small for most institutional managers, who must meet minimum liquidity rules before they even open its books. That size, not a hidden flaw, explains most of the discount.

Lagardère, which owns the Relay newsstands and Elle magazine among other assets, sits in a different situation that leads to the same outcome: a low price despite sales growing 16.2% a year on average. Since Vivendi, controlled by the Bolloré family, completed its takeover of the group after a tender offer launched in 2022, it has held about 60% of Lagardère's capital. When a majority shareholder holds such a stake, minority shareholders carry little weight over management decisions, mergers, or capital distribution. The market then applies what is called a control discount: a lower price to compensate for the other shareholders' lack of real say, even when the underlying business is doing fine.

AXA illustrates a third mechanism specific to insurance: float. An insurer collects premiums from customers today and only pays claims later, sometimes years later for life insurance. In between, it invests money that is not yet its own. This float looks like debt on a standard balance sheet, but it is not one, and that is exactly what makes many investors wary of the sector, which they see as opaque. Yet in the first half of 2026, AXA reported an operating result of 4.5 billion euros, up 4% year over year, with property and casualty up 6% and life and health up 11%, on 66.3 billion euros of revenue. Profitability is rising, while the price stays compressed by that structural distrust of the sector.

Why Hermès and Vinci trade so much more expensive

At the other end of the ranking, Hermès is the priciest of the 21. The leather goods and fashion house raises its prices almost every year, on customers willing to pay more for a bag rather than wait for a discount, sometimes via a waiting list. That is pricing power with almost no equivalent in retail. Over five years, its sales have grown 15.5% a year on average, and its free cash flow margin reaches 26.3%, meaning that out of every 100 euros of sales, more than 26 end up as cash the company can actually use. The market pays top price for this engineered scarcity, 38.3 times free cash flow, against 1.8 for Cegedim.

Vinci illustrates a second, different lever: the concession. When the French state grants Vinci the right to build and operate a highway or an airport for several decades, in exchange for an upfront investment, the company then collects tolls or fees for the entire length of the contract, without a competitor on that specific stretch. In July 2026, Vinci was in fact named preferred bidder for the future A154-A120 highway, a new 97-kilometer stretch west of Paris, for a 35-year term. That kind of contract is worth more to the market than a fast-growing but uncertain business, because the revenue itself is nearly guaranteed for decades. Traffic on existing highways still fell 2.9% in the first half of 2026, hurt by fuel prices and heat waves, without denting the market's confidence: one half-year of lower traffic does not undo a 35-year contract.

Why none of these 21 stocks triggers my buy signal

My site calculates, for every stock, a signal I call opportunity. It only fires if two conditions are met at the same time: P/FCF must be below an absolute threshold AND below the tenth percentile of the stock's own five-year history, meaning among the lowest levels that specific stock has ever reached. The first condition alone is not enough: a stock can look cheap in absolute terms while still being expensive relative to its own past.

Among these 21 French stocks, none checks both boxes at once today, including Cegedim despite its P/FCF of 1.8. My model even shows, for Cegedim, a theoretical fair buy price far above the current stock price, which would imply a discount of several hundred percent if taken literally. I distrust that kind of extreme number: on a micro-cap with a temporarily compressed free cash flow, such a gap mostly signals that the model is extrapolating from too narrow a cash base, not that a real bargain exists at this price. A low P/FCF is never a buy signal on its own, only a starting point worth digging into.

What I do with this ranking

I never turn this kind of table into an automatic buy list. What comes out of it is more like a map: 21 names worth a real look, each with a different reason for costing what it costs, size, control structure, sector opacity, or brand power. The next step, ticker by ticker, is exactly what my site does for any French or foreign stock, separating quality from price and giving you a fair buy price instead of a vague opinion.

That is exactly what I wanted to be able to do in a few seconds for any stock listed in France, so I built my investment site to do it.

Five takeaways

• Twenty-one French stocks pass 8 or 9 of my 10 quality criteria today, from micro-caps to a global multinational.
• Their valuation ranges from 1.8 to 38.3 times free cash flow, a gap of more than twenty times between the two extremes, at nearly identical quality.
• The cheapest ones, Cegedim, Lagardère, and AXA, are cheap for structural reasons: size, control structure, or sector opacity, not because their business is deteriorating.
• The priciest ones, Hermès and Vinci, owe their price to a real moat: brand power for one, long-term concessions for the other.
• None of the 21 triggers my buy signal today: a low price is never a bargain on its own, only a starting point worth digging into.

FAQ

What is P/FCF, the ratio used in this ranking?

P/FCF (price-to-free-cash-flow) compares a stock's price to the free cash flow it generates each year, the money that is really available once every bill and every investment is paid. A P/FCF of 10 means you are paying ten years of that cash to own the stock. The lower it is, the cheaper the stock is relative to the cash it actually produces.

Why can a quality stock stay cheap for a long time?

Often for reasons unrelated to the quality of the business: a market cap too small to attract large investors, like Cegedim, a majority shareholder that limits minority shareholders' power, like Lagardère, or a sector seen as opaque, like insurance for AXA. The market prices in far more than financial results alone.

What is my model's buy signal, and why doesn't it fire for any of these 21 stocks?

It requires a P/FCF below an absolute threshold AND below the tenth percentile of the stock's own five-year history. Among these 21 French stocks, none meets both conditions at once today, including the ones that look cheapest on paper, whose low price comes from structural factors rather than a real market opportunity.

Are these 21 stocks eligible for a French PEA account?

The vast majority, yes: a stock from a company headquartered in the European Union, listed on a regulated or organized market like Euronext Paris or Euronext Growth, is eligible for a PEA. That is the case for all 21 companies in this ranking, all listed in Paris.

Should you buy the cheapest one on the list, Cegedim?

Not just because it shows the lowest P/FCF. My model does not trigger a buy signal on Cegedim: its size limits liquidity, and the valuation gap my model shows is so extreme it needs to be checked in detail before being taken seriously, not followed as is. This is not investment advice, do your own research.

Related reading

• Asset managers in the market: my 2026 ranking
• AZZ: results published under pressure
• Paychex (PAYX): Q4 earnings, my verdict

Analyze a stock on Lubin Investment

About the author

Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I find fundamental analysis fascinating, and it has delivered excellent results. For three years now, my performance has beaten the S&P 500. But analyzing every stock took too much time: sites with incomplete data, calculation methods and criteria never aligned with mine. And spotting the best stocks was just as time-consuming, even with my own well-defined checklist. So I put my software development background to work to build this software, base my investment strategy on its results, and share it with people who share the same passion as me. It judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).